One feels you are rather confused, never implied they should withdraw but have been very critical of a2m management and there ability to inform shareholders and be on the front foot in the FDA application and new markets in general.
the critism is fully deserved.
A2M Price at posting:
$4.72 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)